Skip to content

Efficacy and Safety of Esketamine for Supplemental Analgesia During Elective Cesarean Delivery

Efficacy and Safety of Esketamine for Supplemental Analgesia During Elective Cesarean Delivery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083024
Enrollment
Unknown
Registered
2024-04-15
Start date
2024-04-15
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstetric Anesthesia

Interventions

Sponsors

Dept. of Anesthesiology International Peace Maternity & Child Health Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 40 Years

Inclusion criteria

Inclusion criteria: Women aged 22-40 years, single birth, head position, term, ASA grade II, and undergoing elective cesarean section

Exclusion criteria

Exclusion criteria: Pregnant women with absolute and relative contraindications to spinal anesthesia, allergies to local anesthetics, severe heart and lung basic ASA grading III-IV, preoperative detection of fetal distress, fetal malformations, or multiple pregnancies

Design outcomes

Primary

MeasureTime frame
Maternal Intraoperative Situation;

Secondary

MeasureTime frame
Neonatal outcome;Plasma concentration of Ketamine;Maternal postoperative outcome;

Countries

China

Contacts

Public ContactXiaoyu Zhang

Dept. of Anesthesiology, International Peace Maternity & Child Health Hospital, Shanghai Jiaotong University School of Medicine

xyzhang1986@sina.com+86 21 6407 0434

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026